Clinical Trial Update: RIvoraxaban in Mitral Stenosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for rivaroxaban in mitral stenosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Mitral Stenosis
• Rheumatic Heart Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Rajaie Cardiovascular Medical and Research Center | Conditions: Mitral Stenosis, Rheumatic Heart Disease | Phase 3 | Status: TERMINATED